Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee.
Clinical Cancer Research.
Times cited: 1
2'-fluoro-5-iodoarabinosylcytosine, a new potent antiviral agent: Efficacy in immunosuppressed individuals with herpes zoster.
Palliative and Supportive Care.
Times cited: 20
Primary osteogenic sarcoma of the femur: A model for the use of preoperative chemotherapy in high risk malignant tumors.
Seminars in Interventional Radiology.
Times cited: 37